Table:
begin	end	state
1	41	cytoplasmic
42	58	transmembrane
59	66	non-cytoplasmic
67	88	transmembrane
89	99	cytoplasmic
100	120	transmembrane
121	125	non-cytoplasmic
126	153	transmembrane
154	165	cytoplasmic
166	191	transmembrane
192	199	non-cytoplasmic
200	219	transmembrane
220	257	cytoplasmic
258	280	transmembrane
281	291	non-cytoplasmic
292	312	transmembrane
313	323	cytoplasmic
324	342	transmembrane
343	347	non-cytoplasmic
348	369	transmembrane
370	384	cytoplasmic
385	409	transmembrane
410	415	non-cytoplasmic
416	436	transmembrane
437	447	cytoplasmic

Input:
>Pf6N2E2_388
MQTSLLSNSETHHEHVDDEKKKSMKNVVAGSLFGTALETYDLYLYGTAAALIFAPLFFPG
TDEAVSRLASLASFAISFVARPLGSLVLGHFGDRIGRKKLLYLTLIIMGLSTVGIGLLPT
YASVGIWAPIMLCVLRFIQGFAFAGEYSGAVLMLLEHAPRRKRGFYAAINNIGPVFGFIA
SAGLLLIVSSLLSVEDFYKWGWRIPFIASLALLVVGVFVRSKVAESPVFEKTAEKRAVAK
GPDLSPAMRLFTKYPKQLLLVAGANICHFSTFYLFTVFALSYGQKELGLSNAFVLAVAMV
AICTHLVIVPFAGAMADRLGRRTMMLIGFAVTALAAFPFWHLFSTGQFLPMVLGSCLFMA
GYGLVYGAVPSFTGEAFGPSARFTGFAMATNVGGIIGGGTAPIVGAYLLSHYGSPYAISV
YTVVLAAISALCVYLSAETRTINITDE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server